Revvity, Inc. Common Stock · Transaction May 4, 2026 · Filed Jun 8, 2026 · $15,001 to $50,000
NEW YORK STOCK EXCHANGE, INC. · RVTY
-2.24% · -$3.28 · Vol 3.3M
Market closed · last close 4:00 PM ET · price as of 19:00:00 ET
Revvity Inc
Life Sciences Tools & Services
$143.45
Follow $RVTY
One email when a member of Congress discloses a trade in it, with the official filing receipt linked.
Free. No account. Unsubscribe in one click.
Follow $RVTY by emailVeridion Score
BETAMEDIUM CONF · 5 of 6 factors measuredFri Sep 18 · last completed session · Markets closed · resumes Mon 9:30 ET · RVTY
MethodologyAnalyst data unavailable at compute time
RVTY
Revvity Inc
Fri Sep 18 · last completed session · Markets closed · resumes Mon 9:30 ET
Upper range
Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
74/ 100
Veridion Score
Upper range · MEDIUM confidence · 5 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: MEDIUM · 5 of 6 factors measured · Fri Sep 18 · last completed session · Markets closed · resumes Mon 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
SovereignWhy is RVTY moving today?
Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Revvity Inc
LABORATORY ANALYTICAL INSTRUMENTSListed since
1972
Employees
11K
Country
US
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.
Key statistics
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Open
$146.50
Day high
$146.88
Day low
$142.45
Previous close
$146.73
52W high
$146.88
-2.34% from high
52W low
$82.26
95% of range
Market cap
$16.4B
P/E
84.88×
EPS
$1.69
Beta
0.46
Shares out
111.6M
Volume
3.3M
1.89× rel vol
Avg volume
1.8M
VWAP
$143.80
Price history computed in-house
1W
+15.40%
1M
+15.56%
3M
+43.45%
1Y
+65.42%
YTD
+48.27%
SMA 50 $120.22 · above
SMA 200 $103.89 · above
52W position 95%
RVTY overview
Related filings and maps
Public disclosures
Congress activity in RVTY
Official filing ↗
RVTY · Transaction May 4, 2026 · Filed Jun 8, 2026 · $15,001 to $50,000
RVTY · Transaction May 1, 2026 · Filed May 8, 2026 · $1,001 to $15,000
Revvity, Inc. Common Stock · Transaction May 1, 2026 · Filed May 8, 2026 · $1,001 to $15,000
RVTY · Transaction Sep 12, 2025 · Filed Oct 10, 2025 · $1,001 to $15,000
Federal contracts
RVTY contract awards, year to date.
Public federal awards linked to this ticker.
Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for RVTY in this window.
Lobbying spend
RVTY lobbying filings, year to date.
Registered lobbying filings matched to Revvity Inc.
$105.0K
Refresh interval: 12hSource: LDA disclosure filings
Health IssuesHealth Issues
Medical/Disease Research/Clinical Labs
Filing
$40.0K
REVVITY INC.
REVVITY, INC.
Jul 13, 2026
Filing
$35.0K
REVVITY INC.
REVVITY, INC.
Apr 23, 2026
Filing
$30.0K
REVVITY INC.
REVVITY, INC.
Jan 9, 2026
Analyst ratings
Sovereign unlock shows live analyst consensus for RVTY.
Options
Sovereign unlock shows live options positioning for RVTY.